COLDA will feature an exceptional program with invited lectures, round table discussions and interactive participation from delegates.

The draft program is published below:
*Updated February 26


Thursday September 13 2018

 09:30Registration and walk in coffee
 Introduction to Viral Hepatitis and Liver Disease
 10:30Clinical spectrum of liver disease in africa
 11:00The ABC of viral hepatitis
Mark Thursz, MRCP,
Imperial College, St Mary's Hospital, UK
 11:30Essential diagnostic tools for viral hepatitis
Elijah Songok, MSc, PhD,
KEMRI, Kenya
 12:30     Opening of the Conference
               Conference Chairs

The global challenge of viral hepatitis 
John Ward, MD,
Centers for Disease Control and Prevention, USA

 Session 1: Situation of Liver Disease in Africa
 02:30Burden of Liver Disease in North Africa
Ayman Yosry, MD
Cairo University, Egypt

Burden of liver disease in Sub Saharan Africa

 03:45Patient group presentation
Gamal Shiha,
The African Association of patients with liver disease, Egypt
 04:00Coffee / Tea Break
 Session 2: HIV-Hepatitis Coinfections
  04:30HIV and its impact on viral liver disease
Mark Nelson, MD,
Chelsea and Westminster Hospital, United Kingdom
  05:00Hepatitis D - a forgotten foe?
Richard Njouom, PhD,
Centre Pasteur, Cameroon
 06:00Welcome reception

Friday September 14 2018

 08:00Morning coffee / tea
 Session 3: Hepatitis B
  08:30Whats new in hepatitis B (treatment and monitoring) 
Mark Sonderup, BPharm, MBChB, FCP(SA) MMED, 
University of Cape Town, South Africa
  09:00MTC transmission of HBV
Christian Tzeuton, MD
Douala Medical School / Société Camerounaise de Gastro-Enterologie, Cameroon
  09:30Oral abstract presentation
  09:45Oral abstract presentation
 Session 4: Hepatitis C
  10:45Who is at risk of hepatitis C in Africa?
  11:15How to treat HCV in a Resource-Limited settings
Gamal Esmat, MD,
Cairo University, Egypt
  12:00Oral abstract presentation
  12:15Oral abstract presentation
 12:45Poster viewing session & Lunch
 Session 5: Liver Disease in Special Population
 14:45Viral hepatitis in paediatrics (B and C)
Manal El-Sayed, MD,
Ain Shams University, Cairo, Egypt
 15:15Sex workers and MSM- HBV reactivation

Other special populations (PWID)
John Rwegasha, MBChB, M.MED, FRCP, MSc -
Muhimbili National Hospital, Tanzania

 Session 6: Future issues in liver disease in Africa
  4:45Alcoholic liver disease 
Kosh Agarwal, MD, King’s College Hospital, UK
  5:15Drug induced liver disease- such as AntiTb drugs
  5:45Fatty Liver disease
Maud Lemoine, MD, MSc, PhD,
Imperial College, UK
 6:30Workshop dinner

Saturday 15 September

 8:00Morning tea / Coffee
 Session 7: Other infectious liver disease
 08:30Parasitic infections (Schistosomiasis infection, Liver flukes)
Edford Sinkala,
University Teaching Hospital, Lusaka, Zambia
 09:00Hepatitis E
 10:00Tea / Coffee break
 Session 8: Clinical management of End-stage Liver Disease
 10:30Management of end-stage Liver Disease in Resource-Limited Settings
Mark Sonderup,  BPharm, MBChB, FCP(SA) MMED, 
University of Cape Town, South Africa
 11:00Management of Hepatocellular Carcinoma in Africa
Wendy Spearman, MBChB MMed PhD,
University of Cape Town, South Africa 
 11:15Oral abstract presentation
 11:30Best of Poster session: short poster presentations ( 3 slides/ 5minutes)
 Session 9: Liver Disease - Public health issues
 13:30Improving access to treatment in Resource Limited Settings
Manal El-Sayed, MD,
Ain Shams University, Cairo, Egypt
 14:00New diagnostics to improve diagnosis of liver disease
Francesco Marinucci, PhD
FIND, Italy
 14:30The dangers of not treating-modelling the viral hepatitis epidemic in Africa
Shevanthi Nayagam, MBBS,
Imperial College, UK
 15:00Tea / Coffee break
 Session 10: Round Table Discussion

How can we take the field forward:
- improve access to treatment
- increase monitoring / diagnosis
- identification special patient groups
- involvement policy makers
- standardization treatment approaches / guidelines
Karine Lacombe, MD, PHD,
Saint-Antoine Hospital, France